The mutation spectrum of the former is close to that of endometrial cancer, with common mutations such as CTNNB1, PIK3CA and ARID1A; while the latter is characterized by ARID1A deletion and high expression of HNF1B, which may be related to the immune escape and drug resistance mechanisms (37, 38). The gene discussed is ARID1A; the disease is endometrial cancer.